How to Develop a New Multiplex SARS‑CoV‑2 Variant Neutralizing Antibody Assay in a Day
- Starts
- Ends
- Format
- Online
- Location
- VIRTUAL
About This Event
In this webinar, we will discuss the utilization of Bio‑Plex Pro Human SARS‑CoV‑2 Neutralization Custom Assay Developer Kit to efficiently develop new variant assays for the detection and determination of percentage inhibition of severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) neutralizing antibodies with affinity to SARS‑CoV‑2 variants.